Literature DB >> 26849527

Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection.

Z Kassam1,2, C Cribb Fabersunne3,4, M B Smith1,2, E J Alm1, G G Kaplan5, G C Nguyen6, A N Ananthakrishnan3,7.   

Abstract

BACKGROUND: Clostridium difficile infection (CDI) is a public health threat and associated with significant mortality. However, there is a paucity of objectively derived CDI severity scoring systems to predict mortality. AIM: To develop a novel CDI risk score to predict mortality entitled: Clostridium difficile associated risk of death score (CARDS).
METHODS: We obtained data from the United States 2011 Nationwide Inpatient Sample (NIS) database. All CDI-associated hospitalisations were identified using discharge codes (ICD-9-CM, 008.45). Multivariate logistic regression was utilised to identify independent predictors of mortality. Clostridium difficile associated risk of death score was calculated by assigning a numeric weight to each parameter based on their odds ratio in the final logistic model. Predictive properties of model discrimination were assessed using the c-statistic and validated in an independent sample using the 2010 NIS database.
RESULTS: We identified 77 776 hospitalisations, yielding an estimate of 374 747 cases with an associated diagnosis of CDI in the US, 8% of whom died in the hospital. The eight severity score predictors were identified on multivariate analysis: age, cardiopulmonary disease, malignancy, diabetes, inflammatory bowel disease, acute renal failure, liver disease and ICU admission, with weights ranging from -1 (for diabetes) to 5 (for ICU admission). The overall risk score in the cohort ranged from 0 to 18. Mortality increased significantly as CARDS increased. CDI-associated mortality was 1.2% with a CARDS of 0 compared to 100% with CARDS of 18. The model performed equally well in our validation cohort.
CONCLUSION: Clostridium difficile associated risk of death score is a promising simple severity score to predict mortality among those hospitalised with C. difficile infection.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 26849527      PMCID: PMC5094350          DOI: 10.1111/apt.13546

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  40 in total

1.  Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain.

Authors:  François Lamontagne; Annie-Claude Labbé; Olivier Haeck; Olivier Lesur; Mathieu Lalancette; Carlos Patino; Martine Leblanc; Michel Laverdière; Jacques Pépin
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

2.  Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.

Authors:  Mary Y Hu; Kianoosh Katchar; Lorraine Kyne; Seema Maroo; Sanjeev Tummala; Valley Dreisbach; Hua Xu; Daniel A Leffler; Ciarán P Kelly
Journal:  Gastroenterology       Date:  2008-12-13       Impact factor: 22.682

Review 3.  Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.

Authors:  Christina M Surawicz; Lawrence J Brandt; David G Binion; Ashwin N Ananthakrishnan; Scott R Curry; Peter H Gilligan; Lynne V McFarland; Mark Mellow; Brian S Zuckerbraun
Journal:  Am J Gastroenterol       Date:  2013-02-26       Impact factor: 10.864

4.  Clostridium difficile infection worsens the prognosis of ulcerative colitis.

Authors:  María E Negrón; Herman W Barkema; Kevin Rioux; Jeroen De Buck; Sylvia Checkley; Marie-Claude Proulx; Alexandra Frolkis; Paul L Beck; Levinus A Dieleman; Remo Panaccione; Subrata Ghosh; Gilaad G Kaplan
Journal:  Can J Gastroenterol Hepatol       Date:  2014 Jul-Aug

5.  The economic burden of Clostridium difficile.

Authors:  S M McGlone; R R Bailey; S M Zimmer; M J Popovich; Y Tian; P Ufberg; R R Muder; B Y Lee
Journal:  Clin Microbiol Infect       Date:  2011-06-10       Impact factor: 8.067

6.  Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan; Emily L McGinley; Kia Saeian; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2010-09-07       Impact factor: 5.325

7.  Costs of nosocomial Clostridium difficile-associated diarrhoea.

Authors:  R-P Vonberg; C Reichardt; M Behnke; F Schwab; S Zindler; P Gastmeier
Journal:  J Hosp Infect       Date:  2008-07-07       Impact factor: 3.926

8.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.

Authors:  A N Ananthakrishnan; E L McGinley; D G Binion
Journal:  Gut       Date:  2007-09-28       Impact factor: 23.059

9.  Effect of ribotype on all-cause mortality following Clostridium difficile infection.

Authors:  T Inns; R Gorton; A Berrington; A Sails; T Lamagni; J Collins; J Perry; K Hill; J Magee; K Gould
Journal:  J Hosp Infect       Date:  2013-06-10       Impact factor: 3.926

10.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

View more
  24 in total

1.  Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients.

Authors:  Emily N Tixier; Elijah Verheyen; Ryan C Ungaro; Ari M Grinspan
Journal:  Aliment Pharmacol Ther       Date:  2019-10-14       Impact factor: 8.171

2.  The Impact of Bariatric Surgery on Short Term Risk of Clostridium Difficile Admissions.

Authors:  Hisham Hussan; Emmanuel Ugbarugba; Michael T Bailey; Kyle Porter; Bradley Needleman; Sabrena Noria; Benjamin O'Donnell; Steven K Clinton
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

3.  Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database.

Authors:  Edward L Barnes; Bharati Kochar; Millie D Long; Michael D Kappelman; Christopher F Martin; Joshua R Korzenik; Seth D Crockett
Journal:  Inflamm Bowel Dis       Date:  2017-06       Impact factor: 5.325

4.  The Burden of Hospital Readmissions among Pediatric Patients with Inflammatory Bowel Disease.

Authors:  Edward L Barnes; Bharati Kochar; Millie D Long; Christopher F Martin; Seth D Crockett; Joshua R Korzenik; Michael D Kappelman
Journal:  J Pediatr       Date:  2017-10-14       Impact factor: 4.406

5.  Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles.

Authors:  J R Allegretti; S Kearney; N Li; E Bogart; K Bullock; G K Gerber; L Bry; C B Clish; E Alm; J R Korzenik
Journal:  Aliment Pharmacol Ther       Date:  2016-04-18       Impact factor: 8.171

6.  External Validation and Comparison of Clostridioides difficile Severity Scoring Systems.

Authors:  D Alexander Perry; Daniel Shirley; Dejan Micic; Pratish C Patel; Rosemary Putler; Anitha Menon; Vincent B Young; Krishna Rao
Journal:  Clin Infect Dis       Date:  2022-06-10       Impact factor: 20.999

7.  Ten-year trends and prediction model of 30-day inpatient mortality for alcoholic hepatitis in the United States.

Authors:  Hassam Ali; Rahul Pamarthy; Nicole Leigh Bolick; Muhammad Fahd Farooq
Journal:  Ann Gastroenterol       Date:  2022-05-12

8.  Clostridium Difficile-Associated Infection in Trauma Patients: Development of the Clostridium Difficile Influencing Factors (CDIF) Score.

Authors:  Efstathios Karamanos; Arielle Hodari Gupta; Cletus Nor Stanton; Adhnan Mohamed; Joe H Patton; Nathan Schmoekel
Journal:  Perm J       Date:  2018

9.  Predictors of Mortality Among a National Cohort of Veterans With Recurrent Clostridium difficile Infection.

Authors:  Haley J Appaneal; Aisling R Caffrey; Maya Beganovic; Sanja Avramovic; Kerry L LaPlante
Journal:  Open Forum Infect Dis       Date:  2018-07-19       Impact factor: 3.835

10.  Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration.

Authors:  O H Negm; B MacKenzie; M R Hamed; O A J Ahmad; C C Shone; D P Humphreys; K Ravi Acharya; C E Loscher; I Marszalowska; M Lynch; M H Wilcox; T M Monaghan
Journal:  Clin Exp Immunol       Date:  2017-03-16       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.